Explore the challenges of defining and measuring “quality” IRB review and certain key efforts by research community stakeholders to overcome such obstacles.
Try the industry’s first open access financial burden calculator to help patients, sponsors, and other stakeholders estimate the cost burden patients may face.
Check out this discussion from Clinical Leader Live on why many sites are still relying on paper-based systems and what "e" technologies are helping and increasing in adoption.
James Gillespie, Ph.D., and Gregory Privitera, Ph.D. discuss three overlapping categories of concern when it comes to DCTs: consent and selection, user experience, and comfort and privacy.
This website uses cookies to ensure you get the best experience on our website. Learn more